AAAAAA
Results:
1-17
|
Results: 17
Authors:
LAUTERMANN J
ADAMCZYK M
TENCATE WJF
KLOKE O
Citation: J. Lautermann et al., CARBOPLATIN-INDUCED HEARING-LOSS, Laryngo-, Rhino-, Otologie, 77(2), 1998, pp. 82-84
Authors:
NOWROUSIAN MR
WELT A
FOSSA A
KASPER C
SCHRODER J
KUHLMANN S
SCHUTTE J
KLOKE O
STUSCHKE M
SCHULEHEIN K
METZ KA
LEDER LD
SACK H
SEEBER S
Citation: Mr. Nowrousian et al., RESPONSE-ADAPTED SEQUENTIAL COMBINATION CHEMOTHERAPY (CEBOPP VIML) FOLLOWED BY RADIOTHERAPY FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE/, Annals of oncology, 9, 1998, pp. 514-514
Authors:
ALAMIN A
LENNARTZ K
RUNDE V
SEEBER S
OPALKA B
KLOKE O
Citation: A. Alamin et al., FREQUENCY OF CLONAL B-LYMPHOCYTES IN CHRONIC MYELOGENOUS LEUKEMIA EVALUATED BY FLUORESCENCE IN-SITU HYBRIDIZATION, Cancer genetics and cytogenetics, 104(1), 1998, pp. 45-47
Authors:
WELT A
ANHUF J
KRAWCZYK C
FOSSA A
STUSCHKE M
KLOKE O
SCHUTTE J
WESTERHAUSEN M
SACK H
SEEBER S
NOWROUSIAN MR
Citation: A. Welt et al., INITIAL HIGH-DOSE SEQUENTIAL CHEMOTHERAPY IN THE TREATMENT OF AGGRESSIVE NON-HODGKIN LYMPHOMAS WITH RISK-FACTORS, British Journal of Haematology, 102(1), 1998, pp. 237-237
Authors:
KLOKE O
KUMMER G
SEEBER S
Citation: O. Kloke et al., RAPAMYCIN ANTAGONIZES INTERLEUKIN-6 MEDIATED GROWTH ARREST AND DIFFERENTIATION OF MYELOBLASTIC M1 CELLS, Immunology letters, 59(2), 1997, pp. 115-119
Authors:
KIRCH HC
PUTZER B
BROCKMANN D
ESCHE H
KLOKE O
Citation: Hc. Kirch et al., FORMATION OF THE EARLY-REGION-2 TRANSCRIPTION-FACTOR-1-RETINOBLASTOMA-PROTEIN (E2F-1-RB) TRANSREPRESSOR AND RELEASE OF THE RETINOBLASTOMA PROTEIN FROM NUCLEAR-COMPLEXES CONTAINING CYCLIN A IS INDUCED BY INTERFERON-ALPHA IN U937V CELLS BUT NOT IN INTERFERON-ALPHA-RESISTANT U937VRCELLS, European journal of biochemistry, 246(3), 1997, pp. 736-744
Authors:
OTTINGER HD
BEELEN DW
KASIMIRBAUER S
SCHULTEWOLTER T
REBMANN V
GOOS M
SCHEULEN ME
SEEBER S
SCHAEFER UW
GROSSEWILDE H
KLOKE O
Citation: Hd. Ottinger et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) REDUCES THE CAPACITY OFT-CELLS TO EXPRESS PRO-INFLAMMATORY CYTOKINES AND INCREASES SOLUBLE HLA PLASMA-LEVELS IN HUMANS, Blood, 90(10), 1997, pp. 423-423
Authors:
KLOKE O
NIEDERLE N
OPALKA B
HAWIG I
SEEBER S
BECHER R
Citation: O. Kloke et al., PROGNOSTIC IMPACT OF INTERFERON ALPHA-INDUCED CYTOGENETIC REMISSION IN CHRONIC MYELOGENOUS LEUKEMIA - LONG-TERM FOLLOW-UP, European journal of haematology, 56(1-2), 1996, pp. 78-81
Authors:
SIEBERT R
WILLERS CP
FOSSA A
KLOKE O
NOWROUSIAN MR
SEEBER S
OPALKA B
Citation: R. Siebert et al., ANALYSIS OF THE NOVEL CYCLIN-DEPENDENT KINASE-4 AND KINASE-6 INHIBITOR GENE P18 IN LYMPHOMA AND LEUKEMIA-CELL LINES, Leukemia research, 20(2), 1996, pp. 197-200
Authors:
BECHER R
KLOKE O
HAYUNGS J
HARTWICH G
BARTELS H
SZANTO J
WOLF E
ILLIGER HJ
HALABI S
RIECHE K
HERING KG
OHL S
DEDYCKER R
HUHN R
FISCHEDICK AR
HOFELER H
PIELKEN HJ
HAWIG I
HIRCHE H
SEEBER S
Citation: R. Becher et al., EPIRUBICIN AND IFOSFAMIDE IN METASTATIC BREAST-CANCER, Seminars in oncology, 23(3), 1996, pp. 28-33
Authors:
THIELE J
KVASNICKA HM
NIEDERLE N
ZIRBES TK
SCHMIDT M
DAMMASCH J
MEUTER BR
LEDER LD
KLOKE O
DIEHL V
FISCHER R
Citation: J. Thiele et al., THE IMPACT OF INTERFERON VERSUS BUSULFAN THERAPY ON THE RETICULIN STAIN-MEASURED FIBROSIS IN CML - A COMPARATIVE MORPHOMETRIC STUDY ON SEQUENTIAL TREPHINE BIOPSIES, Annals of hematology, 70(3), 1995, pp. 121-128
Authors:
THIELE J
KVASNICKA HM
NIEDERLE N
KLOKE O
SCHMIDT M
LIENHARD H
ZIRBES T
MEUTER RB
LEDER LD
FISCHER R
Citation: J. Thiele et al., CLINICAL AND HISTOLOGICAL FEATURES RETAIN THEIR PROGNOSTIC IMPACT UNDER INTERFERON THERAPY OF CML - A PILOT-STUDY, American journal of hematology, 50(1), 1995, pp. 30-39
Authors:
KIRCH HC
PUTZER B
KUHLMANN S
BROCKMANN D
ESCHE H
KLOKE O
Citation: Hc. Kirch et al., CELL-DENSITY DEPENDENT GROWTH REDUCTION IN INTERFERON ALPHA-RESISTANTU937 VR UNRAVELS DIFFERENT MECHANISMS OF E2F(-1) INACTIVATION, Experimental hematology, 23(8), 1995, pp. 780-780
Authors:
BEELEN DW
GRAEVEN U
ELMAAGACLI AH
NIEDERLE N
KLOKE O
OPALKA B
SCHAEFER UW
Citation: Dw. Beelen et al., PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME, Blood, 85(10), 1995, pp. 2981-2990
Authors:
WANDL UB
BUTZLER R
NIEDERLE N
KLOKE O
MENGELKOCH B
BECHER R
SEEBER S
OPALKA B
Citation: Ub. Wandl et al., BCR-ABL-POSITIVE AND BCR-ABL-NEGATIVE CLONOGENIC CELLS IN CML PATIENTS UNDERGOING LONG-TERM INTERFERON TREATMENT, Leukemia, 8(5), 1994, pp. 776-779
Authors:
NIEDERLE N
MENGELKOCH B
DOBERAUER C
KLOKE O
WANDL U
Citation: N. Niederle et al., TREATMENT OF METASTATIC CARCINOID-TUMOR A ND THE CARCINOID-SYNDROME WITH RECOMBINANT INTERFERON-ALPHA, Tumordiagnostik & Therapie, 15(5), 1994, pp. 192-196
Authors:
KLOKE O
Citation: O. Kloke, COMBINATION THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALFA AND OTHER CYTOKINES, Seminars in hematology, 30(3), 1993, pp. 22-23
Risultati:
1-17
|